An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells

Background: A major mechanism of action for therapeutic antibodies is antibody-dependent cell-mediated cytotoxicity (ADCC). ALT-803 is an interleukin-15 superagonist complex that enhances ADCC against human carcinoma cells in vitro and exerts an antitumor activity in murine, rat, and human carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fantini, Massimo, David, Justin M., Wong, Hing C., Annunziata, Christina M., Arlen, Philip M., Tsang, Kwong Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482908/
https://www.ncbi.nlm.nih.gov/pubmed/30601063
http://dx.doi.org/10.1089/cbr.2018.2628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482908/
https://www.ncbi.nlm.nih.gov/pubmed/30601063
http://dx.doi.org/10.1089/cbr.2018.2628

Ejemplares similares